Suchergebnisse - "Ogiwara, Kenichi"

PubPharm (142)

1

Reduced plasma factor X is associated with a lack of response to recombinant activated factor VII in patients with hemophilia A and inhibitor, but does not impair emicizumab-driven hemostasis in vitro

enthalten in: Thrombosis research | 2024

von Yada, K. | Fujitate, N. | Ogiwara, K. | +3

2

Antithrombin exhibits anticoagulant effects on the emicizumab-based engineered bispecific antibody (NXT007)-mediated blood coagulation

enthalten in: Thrombosis research | 2024

von Nakajima, Y. | Ogiwara, K. | Inaba, K. | +2

3

Force-sensing treadmill gait analysis system can detect gait abnormalities in haemophilia patients without arthropathy

enthalten in: Haemophilia : the official journal of the World Federation of Hemophilia | 2024

von Mawarikado, Y. | Sakata, A. | Inagaki, Y. | +10

4

Anticoagulant effects of protein C, protein S, and antithrombin levels on the protein C pathway in young children

enthalten in: International journal of hematology | 2024

von Nakagawa, T. | Ogiwara, K. | Tonegawa, H. | +3

5

Emicizumab-mediated hemostatic function assessed by thrombin generation assay in an in vitro model of factor VIII-depleted thrombophilia plasma

enthalten in: International journal of hematology | 2024

von Yada, K. | Ogiwara, K. | Shimonishi, N. | +4

6

Coagulation potentials of plasma-derived factors VIIa and X mixture (Byclot® ) evaluated by global coagulation assay in patients with acquired haemophilia A

enthalten in: Haemophilia : the official journal of the World Federation of Hemophilia | 2024

von Takeyama, M. | Furukawa, S. | Ogiwara, K. | +7

7

Hybrid human-porcine factor VIII proteins partially escape the inhibitory effects of anti-factor VIII inhibitor alloantibodies having A2 or C2 domain specificity

enthalten in: Haemophilia : the official journal of the World Federation of Hemophilia | 2024

von Mizumachi, K. | Nakajima, Y. | Shimonishi, N. | +4

8

NXT007-mediated hemostatic potential is suppressed by activated protein C-catalyzed inactivation of activated factor V

enthalten in: Research and practice in thrombosis and haemostasis | 2024

von Nakajima, Y. | Ogiwara, K. | Inaba, K. | +2

9

Hemostatic potential of recombinant von Willebrand factor and standard or pegylated extended half-life recombinant factor VIII on thrombus formation under high shear flow

enthalten in: Thrombosis journal | 2023

von Yaoi, H. | Shida, Y. | Ogiwara, K. | +1

10

Hemostatic potential of recombinant von Willebrand factor and standard or pegylated extended half-life recombinant factor VIII on thrombus formation under high shear flow

enthalten in: Thrombosis journal | 2023

von Yaoi, H. | Shida, Y. | Ogiwara, K. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]